As of 3:27pm ET
| +0.05 / +1.96%|
The 4 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 10.50, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +303.85% increase from the last price of 2.60.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.